9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020

Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110. doi: 10.2337/dc20-S009.

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Publication types

  • Historical Article
  • Practice Guideline
  • Review

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / therapy*
  • Endocrinology / methods
  • Endocrinology / organization & administration
  • Endocrinology / standards
  • Glycemic Control / methods
  • Glycemic Control / standards*
  • History, 21st Century
  • Humans
  • Hypoglycemic Agents / standards
  • Hypoglycemic Agents / therapeutic use*
  • Reference Standards
  • Societies, Medical / history
  • Societies, Medical / organization & administration
  • Societies, Medical / standards
  • Standard of Care / history
  • Standard of Care / standards
  • Standard of Care / trends
  • United States / epidemiology

Substances

  • Blood Glucose
  • Hypoglycemic Agents